Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
Arikawa
Junko
J
Okabe
Seigo
S
Kaneko
Takehiko
T
D000279:Administration, Cutaneous; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D002019:Bufexamac / Q000008:administration & dosage / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000209:etiology* / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D010328:Patch Tests
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002019:Bufexamac